Drug Trial Radar · NCT03769090
A Study to Assess the Efficacy and Safety of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) in Adults and Children 4 Years of Age or Older With Asthma
Last checked: Nov 19, 2026Latest source record: Sep 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,132
Actual
Start
Dec 13, 2018
Primary completion
Aug 19, 2021
Study completion Feb 7, 2022
Sponsor
- Lead sponsor
- Bond Avillion 2 Development LPIndustry
- Sponsor type
- Industry
- First posted
- Dec 7, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 4 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a randomized, double-blind, multicenter, parallel-group, variable-length study to compare 2 doses of BDA MDI (PT027) with AS MDI (PT007) on the time to first severe asthma exacerbation in adult, adolescent, and pediatric subjects with moderate to severe asthma.
Conditions
- Asthma
Interventions
Budesonide/albuterol sulfate metered-dose inhaler 160/180 μgCombination product
Budesonide/albuterol sulfate combination inhalation aerosol
Budesonide/albuterol sulfate metered-dose inhaler 80/180 μgCombination product
Budesonide/albuterol sulfate combination inhalation aerosol
Albuterol sulfate metered-dose inhaler 180 μgDrug
Albuterol sulfate inhalation aerosol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With a Severe Asthma Exacerbation EventTime frame: From randomization up to a discontinuation of randomized treatment or a change in maintenance therapy. The mean and median reporting period for all participants was 44 and 48 weeks, respectively.
Locations
345 sites in 11 countries. Site status is shown where the registry gives one.
Research Site
Birmingham, Alabama
Research Site
Huntsville, Alabama
Research Site
Mobile, Alabama
Research Site
Montgomery, Alabama
Research Site
Scottsboro, Alabama
Research Site
Sheffield, Alabama
Research Site
Tuscumbia, Alabama
Research Site
Glendale, Arizona
Research Site
Peoria, Arizona
Research Site
Scottsdale, Arizona
Research Site
Little Rock, Arkansas
Research Site
Bakersfield, California
Research Site
Bellflower, California
Research Site
Canoga Park, California
Research Site
Encinitas, California
Research Site
Hawthorne, California
Research Site
Long Beach, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Los Angeles, California
Research Site
Newport Beach, California
Research Site
Rancho Cucamonga, California
Research Site
Redwood City, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
San Jose, California
Research Site
Westminster, California
Research Site
Aurora, Colorado
Research Site
Colorado Springs, Colorado
Research Site
Colorado Springs, Colorado
Research Site
Denver, Colorado
Research Site
Denver, Colorado
Research Site
Denver, Colorado
Research Site
Waterbury, Connecticut
Research Site
Aventura, Florida
Research Site
Boynton Beach, Florida
Research Site
Cape Coral, Florida
Research Site
Clearwater, Florida
Research Site
Clearwater, Florida
Showing 40 of 345 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.